JoVE Logo

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Protocol
  • Discussion
  • Disclosures
  • Materials
  • References
  • Reprints and Permissions

Summary

This video demonstrates the induction and clinical scoring of an animal model of multiple sclerosis: chronic-relapsing experimental autoimmune encephalomyelitis in DA rats. The disease, induced by immunizing rats with an emulsion containing whole rat spinal cord and complete Freund's adjuvant, presents clinical signs resembling the human disease.

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that commonly affects young adults. It is characterized by demyelination and glial scaring in areas disseminated in the brain and spinal cord. These lesions alter nerve conduction and induce the disabling neurological deficits that vary with the location of the demyelinated plaques in the CNS (e.g. paraparesis, paralysis, blindness, incontinence).

Experimental autoimmune encephalomyelitis (EAE) is a model for MS. EAE was first induced accidentally in humans during vaccination against rabies, using viruses grown on rabbit spinal cords. Residues of spinal injected with the inactivated virus induced the CNS disease. Following these observations, a first model of EAE was described in non-human primates immunized with a CNS homogenate by Rivers and Schwenther in 1935. EAE has since been generated in a variety of species and can follow different courses depending on the species/strain and immunizing antigen used. For example, immunizing Lewis rats with myelin basic protein in emulsion with adjuvant induces an acute model of EAE, while the same antigen induces a chronic disease in guinea pigs.

The EAE model described here is induced by immunizing DA rats against DA rat spinal cord in emulsion in complete Freund's adjuvant. Rats develop an ascending flaccid paralysis within 7-14 days post-immunization. Clinical signs follow a relapsing-remitting course over several weeks. Pathology shows large immune infiltrates in the CNS and demyelination plaques. Special considerations for taking care for animals with EAE are described at the end of the video.

Protocol

Induction and monitoring of chronic-relapsing EAE

The emulsion is a 1:1 mixture of antigen in aqueous solution added to supplemented complete Freund's adjuvant. It is very important to add the antigen to the adjuvant and not the other way round!!!

There is a lot of waste when making and injecting an emulsion. Always prepare 1.5 or 2 times more than what you need.

Use autoclaved mortar, pestle, glass syringes, and bridges. All plastics should be sterile. The preparation can be done on a regular laboratory bench.

1. Preparation of the supplemented adjuvant

Weigh 30 mg of Mycobacterium tuberculosis (Difco catalog # 231141) and place into a mortar. Make into thin powder without pressing too hard to avoid breaking the bacteria. Add 10 ml of complete Freund's adjuvant H37Ra (Difco catalog # 231131) and mix. This supplemented adjuvant now contains 4 mg/ml Mycobacterium tuberculosis. Transfer to a tube.

2. Preparation of the spinal cord homogenate

Collect spinal cords from DA rats (age/gender indifferent) and store frozen at -80°C. Weigh the frozen spinal cords to have enough to mix 1:1 (weight:volume) with the supplemented adjuvant. Mince the spinal cords as fine as possible with a razor blade, transfer to the mortar used in section 1, and make a paste with the pestle.

3. Preparation of the emulsion

  1. Place supplemented complete Freund's adjuvant in a tube. Vortex at high speed. Add the spinal cord homogenate drop by drop while vortexing. When all of the spinal cord homogenate is added, vortex for 5 more minutes. The mixture should turn light pink.

  2. Put the emulsion in a 5 ml glass syringe and link it to another 5 ml glass syringe using a 18G bridge (Fisher catalog # 14-825-17L). Send the emulsion from a syringe to the other until it becomes hard (5-10 min). If more than 5 ml of emulsion is prepared, use several 5 ml syringes DO NOT use larger syringes.

  3. The emulsion can be stored in the syringes at 4°C for 3 weeks. I recommend preparing it at least 12 hours in advance to check that it does not break down. It should remain thick and not separate in 2 phases. The color will change overnight to a light yellow or beige.

4. Immunization of the rats

  1. Mix the emulsion in the syringes for a few minutes and transfer to the syringe used for the injection. Inject 200 µl subcutaneously at the very base of the tail using 23G needles and 3 ml Luer-Lock syringes under short-term anesthesia.

  2. The recipients are 7-9 weeks old female DA rats. We get our rats from Harlan-Sprague Dawley.

  3. Rats should be observed twice daily and weighed daily. Clinical signs are expected 7-15 days after injection of the emulsion.

Clinical scoring:

0:         no disease

0.5:      distal limp tail

1:         limp tail

2:         mild paraparesis, ataxia

3:         moderate paraparesis, the rats trips from time to time

3.5:      one hind limb is paralyzed, the other moves

4:         complete hind limb paralysis

5:         complete hind limb paralysis and incontinence

6:         moribund, difficulty breathing, does not eat or drink. Euthanize immediately.

Discussion

There are a few important considerations for this protocol.

Genetics of DA rats will differ slightly depending on which breeder they are bought from. These differences may increase or decrease the susceptibility of rats to EAE induction. If your rats are more susceptible to EAE you will want to reduce the strength of the immunization by using non-supplemented complete Freund's adjuvant or even incomplete Freund's adjuvant. You may also consider reducing the amount of emulsion injected or dilu...

Disclosures

CB and KGC are co-founders and consultants for Airmid Inc.

Materials

NameCompanyCatalog NumberComments
Complete Freund’s AdjuvantReagentFisher ScientificDF 311-360-5Manufactured by Difco
Mycobacterium tuberculosis H37RaReagentFisher ScientificDF3114-33-8Manufactured by Difco
DA ratAnimalHarlan LaboratoriesFemales, 7-9 weeks old.
Glass syringes - 5 mlToolFisher Scientific14-823-10 B
Metal bridge - 18GToolFisher Scientific14-825-17L
Luer Lok plastic syringes - 3 mlToolBD Biosciences309585
Needles - 20G 1 1/2ToolFisher Scientific14-826-5C

References

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

InductionClinical ScoringChronic Relapsing Experimental Autoimmune EncephalomyelitisMultiple SclerosisChronic Inflammatory DiseaseCentral Nervous SystemDemyelinationGlial ScaringBrainSpinal CordDemyelinated PlaquesParaparesisParalysisBlindnessIncontinenceExperimental Autoimmune Encephalomyelitis EAEMS ModelVaccinationRabiesViruses Grown On Rabbit Spinal CordsCNS DiseaseNon human Primates Immunized With A CNS HomogenateSpecies strainImmunizing AntigenLewis RatsMyelin Basic Protein In Emulsion With AdjuvantGuinea PigsDA RatsDA Rat Spinal CordComplete Freund s AdjuvantAscending Flaccid Paralysis

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved